Science Resources RSS Feeds
|
 |
 |
 |
Lymphoma Current Events | Lymphoma News
|
| Page
1 of
7 |
127 Results |
|
|
|
Sort By:
Page Views | Date |
PET-CT detects muscular lymphoma better than CT
PET-CT is better for early detection of muscular lymphoma than CT alone, according to a new study conducted by radiologists at the University of Minnesota in Minneapolis. view more (2007-05-07)
News from Cancer: Risk factors for deadly form of lymphoma
A new study indicates that the incidence of mantle cell lymphoma, an aggressive type of non-Hodgkin's lymphoma, is on the rise, most frequently striking men, Caucasians and older individuals. view more (2008-07-07)
Intense chemotherapy wards off recurrence in half of mantle cell lymphoma patients after seven years
More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as frontline treatment remain in remission seven years later, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th annual meeting of the American Society of Hematology. view more (2008-12-10)
Relaxation and hypnotherapy - successful treatments for lymphoma?
A long term study of patients diagnosed with Hodgkin's disease or non-Hodgkin's lymphoma has found that those who were given relaxation therapy and hypnotherapy as well as chemotherapy were more likely to survive than those receiving chemotherapy on its own. These are the results of a study by Professor Leslie Walker, of Hull University, and Dr... view more... (2001-03-26)
Delaying Chemotherapy Could Be Best Treatment Option For Certain Type Of Non-hodgkin Lymphoma (p 516)
Delaying chemotherapy until symptoms develop for patients with asymptomatic advanced low-grade non-Hodgkin lymphoma is confirmed as an appropriate strategy authors of a UK study in this week's issue of THE LANCET. Chemotherapy (single or aggressive combination therapy) does not cure advanced stage low-grade non-Hodgkin lymphomas, even when... view more... (2003-08-13)
Antibiotic treats lymphoma of the eye
The common antibiotic doxycycline effectively treats a type of lymphoma associated with chlamydia infection. view more (2006-10-04)
New therapy prevents dangerous side effect for lymphoma patients
Patients respond well to a new three-drug combination for indolent B cell lymphoma that also spares them prolonged, potentially lethal, suppression of blood production in the bone marrow, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th annual meeting of the American Society of Hematology. view more (2008-12-10)
Exercise is good medicine for lymphoma patients
A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found. view more (2009-10-28)
Malaria and Epstein-Barr virus linked to pediatric cancer in Africa
Endemic Burkitt lymphoma is a form of cancer that accounts for up to 74% of malignant disorders in children in equatorial Africa. Malaria and Epstein-Barr virus (EBV) are known cofactors in its development, but to date, their relative contribution has not been well understood. view more (2007-06-08)
Antibiotics may not be enough to stop recurrent gastric lymphoma caused by Helicobacter pylori
Research led by Dr. Anne Mueller at Stanford University School of Medicine demonstrates that successful eradication of Helicobacter may not prevent future aggressive gastric lymphoma since resting B cells are left behind. view more (2005-08-25)
FLT PET Assesses Treatment Response on Tumor Growth—Not Size—With Non-Hodgkin's Lymphoma
Positron emission tomography (PET)—with the radiolabeled thymidine analog [18F]Fluorothymidine (FLT)—is "a promising, sensitive tool" for assessing drug effects on tumor growth in patients with diffuse large B-cell lymphoma. view more (2006-06-07)
Every patient is unique: Individualized therapies for non-Hodgkin's lymphoma
Positron emission tomography (PET) could be an important tool for identifying non-Hodgkin's lymphoma patients who are likely to respond well to treatment with 90 ibritumomab tiuxetan (IT)-the first radioimmunotherapy treatment approved for use by the U.S. Food and Drug Administration, said researchers at SNM's 55th Annual Meeting. view more (2008-06-17)
USC researchers find new clues to risk of Hodgkin lymphoma
A long-term study of twins has led University of Southern California (USC) researchers to find potential links between Hodgkin lymphoma and levels of an immune response protein (interleukin-12). view more (2008-04-02)
VCU Massey Cancer Center Spearheads Novel Clinical Study for Lymphoma Patients
The Virginia Commonwealth University Massey Cancer Center recently opened a National Cancer Institute (NCI)-sponsored, phase II clinical study for certain sub-types of non-Hodgkin's lymphoma. view more (2008-09-03)
Model predicts risk of breast cancer for young women treated for Hodgkin lymphoma
Young women who are treated for Hodgkin lymphoma with chest radiation therapy have a high cumulative absolute risk of developing breast cancer later in life. view more (2005-10-05)
Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients
Scientists at Thomas Jefferson University Hospital and Jefferson's Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. view more (2008-01-03)
Adding radioimmunotherapy to chemo may help patients with lymphoma
Patients treated for follicular lymphoma, a slow-growing type of non-Hodgkin's lymphoma, may benefit from chemotherapy followed by radioimmunotherapy, according to a University of Pittsburgh Medical Center (UPMC) study presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago and published as Abstract 8005 in... view more... (2007-06-04)
UNMC researchers help make diagnostic breakthrough with Burkitt lymphoma; study detailed in New England Journal of Medicine
An international research study involving the University of Nebraska Medical Center, the National Cancer Institute and 10 other institutions has successfully identified the gene expression signature for Burkitt lymphoma. view more (2006-06-12)
Anti-inflammatory drugs may defeat a treatment-resistant type of cancer
Effective drugs for treating a chemotherapy-resistant form of lymphoma might already be on the market according to a study that has pieced together a chemical pathway involved in the disease. view more (2009-06-25)
Sunlight reduces risk of lymph gland cancer
A new study from Karolinska Institutet and Uppsala University shows that, contrary to previous belief, sunlight reduces the chances of developing tumours in the lymphatic glands (malignant lymphoma). The study is to be published in the next number of The Journal of the National Cancer Institute. view more (2005-01-28)
|
|
| Page
1 of
7 |
127 Results |
|
|
|
Sort By:
Page Views | Date |
|
|
